Lu F, Zhang X M, Mei B Y
Department of Internal Medicine, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University of Medical Sciences, Guangzhou, China.
Zhongguo Yao Li Xue Bao. 1992 Jul;13(4):364-7.
The effects of propafenone (Pro), a new Ic anti-arrhythmic agent (AAA), quinidine (Qui), and their combination on ventricular fibrillation threshold (VFT) and other electrophysiological properties were evaluated in 20 dogs. VFT was determined by a train of pulses, 4 ms in duration, delivered at 10 ms intervals. The results showed that in normal anesthetized, open-chest dogs: (1) Pro decreased VFT by 21.4%; (2) Qui increased VFT by 75.5%; (3) the Pro-induced decreased VFT was abolished by simultaneous administration of Qui; and (4) the above effects of the two drugs used separately or in combination on VFT were not related to their effects on ventricular effective refractory period and atrioventricular conduction time.
在20只犬中评估了新型Ic类抗心律失常药(AAA)普罗帕酮(Pro)、奎尼丁(Qui)及其联合应用对心室颤动阈值(VFT)和其他电生理特性的影响。VFT通过以10 ms间隔施加的持续时间为4 ms的一串脉冲来测定。结果显示,在正常麻醉、开胸犬中:(1)普罗帕酮使VFT降低21.4%;(2)奎尼丁使VFT升高75.5%;(3)同时给予奎尼丁可消除普罗帕酮所致的VFT降低;(4)这两种药物单独或联合应用对VFT的上述作用与其对心室有效不应期和房室传导时间的作用无关。